Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Neridronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Adverse reactions
- Sponsors Grunenthal
- 16 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Dec 2016 Status changed from not yet recruiting to recruiting.
- 25 Nov 2016 New trial record